“If a business does well, the stock eventually follows.” – Warren Buffet

For me, buying a publicly traded stock is no different than buying an interest in a private business. In either case, I would only invest in a company that’s well-managed, with a valuable product line, and robust profitability.

Furthermore, I would only invest if the company is outperforming its peers and its main competitors.

Boston Scientific is definitely one such company, having generated an average annualized rate of return of 30% over the last three years – five times the return of the overall healthcare sector – and a 24% annualized return over the last five years, well ahead of the S&P 500 Index’s 13%.

That is quite impressive considering that most healthcare stocks have badly lagged the broad market retu

See Full Page